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Campylobacter is the most common bacterial cause of human gastroenteritis in the
world, with the species Campylobacter jejuni being responsible for over 80% of Campylobacter
infections [1]. C. jejuni is abundant within the avian gut and the consumption and han-
dling of poultry is the main route of transmission to humans [2,3]. In humans, C. jejuni
infection ranges from asymptomatic carriage to bloody diarrhoea, fever and abdominal
pains as well as serious post-infectious sequelae such as the neuromuscular paralysis of
Guillain–Barré syndrome [4]. In low-resource areas, Campylobacter infections are common
in young children (causing watery diarrhoea rather than the bloody diarrhoea that occurs
in high-resource countries) and are associated with many deaths, as well as stunted growth
and life-long physical and cognitive deficiencies [5]. In addition, as highlighted by the
WHO, C. jejuni is a multi-antibiotic-resistant pathogen and new therapeutics are urgently
required [6].
Historically, the lack of a convenient animal model, coupled with genetic diversity and
difficulties in culturing C. jejuni, has hampered pathogenesis research [7]. For this reason,
it is important that the Campylobacter research community continues to investigate this
important human pathogen. This Special Issue was produced with the aim of promoting
the latest research on Campylobacter pathogenicity focusing on a range of topics from
virulence determinants such as lipooligosaccharide (LOS) to functional characterisation
of specific genes of interest. The Special Issue aims to look at novel infection models,
immunological responses of Campylobacter infection and epidemiological studies with the
overarching aim of intervention and control strategies. Survival themes such as biofilms,
antimicrobial resistance and omics-based topics such as the microbiome also form a key
part of the Special Issue. Overall, this Microorganisms Special Issue highlights some of the
most up-to-date research relating to Campylobacter pathogenicity.
Our aim to further understand the pathogenicity and physiology of Campylobacter has
been pursued by a number of research groups. Kovács et al. [8] investigate the virulence
traits of inpatient C. jejuni isolates and apply a transcriptomic approach to identify potential
genes maintaining a role in intracellular survival. Characteristic groups of genes were
identified as significantly upregulated, outlining a survival strategy of internalised C. jejuni,
comprising genes related (1) to oxidative stress; (2) to a protective sheath formed by the
capsule, LOS, N-, and O-glycosylation systems; (3) to dynamic metabolic activity sup-
ported by different translocases and the membrane-integrated component of the flagellar
apparatus; and (4) to hitherto unknown genes. Talukdar et al. [9] investigate C. jejuni CadF
and FlpA virulence proteins in binding to host cell fibronectin. The authors demonstrate
that the C. jejuni CadF and FlpA adhesins facilitate the binding of C. jejuni to the host
cells, permit delivery of effector proteins into the cytosol of a host target cell and aid in the
rewiring of host cell signalling pathways to alter host cell behaviour. Guirado et al. [10]
discuss the differential distribution of the wlaN and cgtB genes, which are associated with
Guillain–Barré Syndrome in C. jejuni isolates from humans, broiler chickens and wild
birds. The authors detect two variants of a G-rich region within the cgtB gene, suggesting
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that, similarly to wlaN, the G-tract in the cgtB gene mediates the phase variation control of
cgtB expression. Guk et al. [11] investigate hyper-aerotolerant C. coli from duck sources
and their increased potential of virulence, antimicrobial resistance and genetic relatedness.
Recently, aerotolerant (AT) C. jejuni with the ability to survive under aerobic stress has
been reported. The authors investigate the prevalence of hyper-aerotolerant (HAT) C. coli
from duck sources with these strains most likely being transmitted to humans through the
food chain given their aerotolerance.
A number of research articles investigate infection models and/or immunological as-
pects of C. jejuni infection. Kløve et al. [12] show that the immunopathological sequelae in C.
jejuni-infected mice were due to Toll-like receptor 4 (TLR4)-dependent immune responses
induced by bacterial LOS. Here, the authors further investigate and identify TLR4 involved
in mediating C. coli LOS-induced immune responses in intestinal and extra-intestinal com-
partments during murine campylobacteriosis. Heimesaat et al. [13] investigate the use of
the polyphenolic compound resveratrol to alleviate acute C. jejuni-induced enterocolitis in a
preclinical intervention study. Functional analyses revealed that resveratrol treatment could
effectively rescue colonic epithelial barrier function in C. jejuni-infected mice. The authors
describe that peroral resveratrol treatment does exert potent disease-alleviating effects
during acute experimental campylobacteriosis. Heimesaat et al. [14] also investigate the
immune-modulatory properties of the octapeptide NAP in C. jejuni-infected mice suffering
from acute enterocolitis. The authors discuss how they used an acute C. jejuni induced ente-
rocolitis model, and they surveyed the anti-pathogenic and immune-modulatory effects of
the octapeptide NAP, which is well-known for its neuroprotective and anti-inflammatory
properties. NAP treatment resulted in less distinct innate and adaptive pro-inflammatory
immune responses that were not restricted to the intestinal tract but could also be observed
in extra-intestinal and even systemic compartments. NAP treatment further resulted in
less frequent translocation of viable pathogens from the intestinal tract to extra-intestinal
areas including systemic tissue sites.
In conjunction with basic laboratory research, applied research is important for us to
investigate Campylobacter in the real world. Rapp et al. [15] study the importance of the farm
environment and wildlife for transmission of C. jejuni, specifically in a pasture-based dairy
herd. The results indicate that management of grazed pasture and supplementary feed con-
taminated by bird droppings could be targeted to effectively reduce transmission of C. jejuni
to dairy herds, the farm environment and, ultimately, to humans. Šimunović et al. [16]
compare C. jejuni from slaughterhouse and surface-water isolates, indicating the better
adaptation of the former to the chicken host environment. The authors highlight adapta-
tion of C. jejuni slaughterhouse isolates to the chicken host, as well as increased biofilm
cell resistance due to increased efflux pump activity. Di Donato et al. [17] investigate the
prevalence, population diversity and antimicrobial resistance of C. coli isolated in Italian
swine at slaughterhouses. The authors identify a strong correlation between phenotypic
and genotypic resistance to fluoroquinolone and tetracycline. Liang et al. [18] investigate
the development of a lyophilisation process for Campylobacter bacteriophage storage and
transport. In this study, the authors describe the development of a lyophilisation ap-
proach to maintain phage titers, ensure efficacy and reduce transport costs of Campylobacter
bacteriophages.
As with all modern science, the use of in silico bioinformatics approaches to study
relevant research questions goes hand in hand with laboratory science. Bandoy and
Weimer [19] use machine learning combined with Campylobacter population genomics to
reveal virulence gene allelic variants that cause disease. The authors validated a novel
framework to define infection mechanism using a combination of a GWAS, machine
learning and bacterial population genomics that ranked allelic variants to identify disease.
The Special Issue also provides three reviews. Pumtang-on et al. [20] perform a
systematic review of C. jejuni vaccine candidates for chickens, highlighting the need for
increased consistency in the way C. jejuni vaccine studies in poultry are designed and
reported in order to be able to undertake a robust comparison of C. jejuni vaccine candidates.
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Mousavi et al. [21] discuss a novel clinical C. jejuni infection model based on sensitisation
of mice to LOS. The review highlights the major role of LOS-driven innate immunity in
pathogenesis of campylobacteriosis, including post-infectious autoimmune diseases, and
promote the preclinical evaluation of novel pharmaceutical strategies for prophylaxis and
treatment. Tram et al. [22] discuss C. jejuni and biofilms. This review examines factors that
can trigger biofilm formation and is a timely reminder of the importance of biofilms in
relation to C. jejuni survival.
This Special Issue highlights the latest developments within Campylobacter research,
particularly those relating to pathogenicity.
Conflicts of Interest: The authors declare no conflict of interest.
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